arginine has been researched along with warfarin in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (7.89) | 18.7374 |
| 1990's | 17 (14.91) | 18.2507 |
| 2000's | 49 (42.98) | 29.6817 |
| 2010's | 35 (30.70) | 24.3611 |
| 2020's | 4 (3.51) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blau, K; Dann, LG | 1 |
| Hauber, G; Schimmer, O | 1 |
| Nomura, K | 1 |
| Loscalzo, J; Scharfstein, J | 1 |
| Funahara, Y; Hijikata-Okunomiya, A; Opartkiattikul, N | 1 |
| Biggins, JA; Gibson, AM; Lauffart, B; Mantle, D; McDermott, JR | 1 |
| Brecher, AS; Burkholder, DE; Burkholder, JS; Howe, WF | 1 |
| Aizawa, S; Hirano, J; Inada, Y; Takenaka, O; Tamaura, Y | 1 |
| Glueck, HI; Wachman, J | 1 |
| Berry, HK; Hsieh, MC | 1 |
| Barrett, AJ | 1 |
| Atkinson, EA; Bleackley, RC; Helgason, CD; Pinkoski, MJ | 1 |
| Braganza, VJ; Hernandez, MA; Kam, CM; Patil, GS; Powers, JC; Simmons, WH; Ueda, T | 1 |
| Arvela, P; Mustajoki, P; Mustajoki, S; Pelkonen, O; Rautio, A | 1 |
| Azam, N; Baburaj, K; Durani, S; Udgaonkar, D | 1 |
| Takahashi, K; Takahashi, T; Tamanoue, Y | 1 |
| Fukase, M; Morita, S; Morita, Y; Yamaguchi, M | 1 |
| Fuller, RS; Krafft, GA; Rockwell, NC; Wang, GT | 1 |
| Fareed, J; Hoppensteadt, DA; Kahn, S | 1 |
| Brandslund, I; Dahler-Eriksen, BS; Larsen, TB; Lassen, JF; Petersen, PH | 1 |
| Gormley, NA; Kampranis, SC; Maxwell, A; Orphanides, G; Tranter, R | 1 |
| Becker, JC; Hursting, MJ; Joffrion, JL; Knappenberger, GD; Schwarz, RP; Zehnder, JL | 1 |
| Jang, IK; Januzzi, JL | 1 |
| Armstrong, PW; Choy, JB | 1 |
| Bhagavan, NV; Ha, CE; Harohalli, K; Park, DS; Petersen, CE | 1 |
| Ataullakhanov, FI; Krasotkina, YV; Sinauridze, EI | 1 |
| Cottrell, KM; Edwards, PD; Furlong, ST; Mauger, RC; Morris, FX; Pine, KK; Scott, CW; Sylvester, MA | 1 |
| DiCicco, RA; Hursting, MJ; Jorkasky, DK; Montague, T; Sheth, SB | 1 |
| Bode, C; Darius, H; Diehm, C; Encke, A; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schrör, T; Schulte, KL; Tebbe, U; Van Aken, H | 1 |
| Cho, JH; Dan, T; Kim, HY; Koga, T; Koo, BA; Seo, HS; Yun, CH | 1 |
| Gordan, L; Gorman, R; Kitchens, C; Zumberg, M | 1 |
| Warkentin, TE | 3 |
| Smythe, MA; Warkentin, TE | 1 |
| Mattson, JC; Smythe, MA; Stephens, JL; Warkentin, TE; Zakalik, D | 1 |
| Brown, PM; Hursting, MJ | 1 |
| Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R | 1 |
| Dickmann, LJ; Jones, JP; Locuson, CW; Rettie, AE | 1 |
| Fritsma, GA | 1 |
| Ding, X; He, XY; Hong, JY; Hu, WY; Lu, AY; Shen, J | 1 |
| Shinohara, Y | 1 |
| White, CM | 1 |
| Bartholomew, JR | 1 |
| Arpino, PA; Demirjian, Z; Van Cott, EM | 1 |
| Carvalho, DC; Garrido, SS; Marchetto, R; Scatigno, AC; Trovatti, E | 1 |
| Hursting, MJ; Lewis, BE; Macfarlane, DE | 1 |
| Bartholomew, JR; Hursting, MJ | 1 |
| Rice, L | 1 |
| Charest, AF; Geerts, WH; Grand'Maison, A | 1 |
| Dager, W; Spinler, SA | 1 |
| Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D | 1 |
| Anraku, M; Iwao, Y; Kawai, K; Kragh-Hansen, U; Maruyama, T; Otagiri, M; Yamasaki, K | 1 |
| Bayry, J; Christophe, O; Dasgupta, S; Delignat, S; Friboulet, A; Hoebeke, J; Kaveri, SV; Kazatchkine, MD; Lacroix-Desmazes, S; Nagaraja, V; Reinbolt, J; Saenko, E; Wootla, B | 1 |
| Kaneko, M; Kohno, H; Muraoka, M; Shikata, H | 1 |
| Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL | 1 |
| Durr, EA; Krueger, CD; Shapiro, NL | 1 |
| Hirata, K; Iwanami, H; Odaka, M | 1 |
| Kloecker, GH; Laber, DA; Martin, ME | 1 |
| Ahmed, I; Majeed, A; Powell, R | 1 |
| Abrahams, S; Louw, VJ; Smedema, JP | 1 |
| Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J | 1 |
| Allen, SL; Barginear, MF; Bhaskaran, M; Bradley, T; Budman, DR; Donahue, L; Shapira, I | 1 |
| Arakawa, T; Kita, Y; Koyama, AH | 1 |
| Diez-Ewald, M | 1 |
| Arakawa, T; Hirano, A; Shiraki, K | 1 |
| Taimeh, Z; Weksler, B | 1 |
| Chong, BH; Isaacs, A | 1 |
| Maldonado, A | 1 |
| Bara, C; Gras, C; Hafer, C; Haverich, A; Kuehn, C; Malehsa, D; Meyer, AL; Strüber, M | 1 |
| Izumi, M; Maruyama, T; Mera, K; Nagai, R; Otagiri, M; Takeo, K | 1 |
| Ichinoe, M; Mikami, T; Okayasu, I; Suzuki, K; Ujiie, S | 1 |
| Ortel, TL | 1 |
| Castellone, DD; Van Cott, EM | 1 |
| Budic, M; Cigić, B; Kidric, M; Meglic, V | 1 |
| Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D | 1 |
| Jain, PG; Kauflin, MJ; Nanda, MM; Yannetta, JC | 1 |
| Becher, T; Berdel, P; Braunstein, J; Gravius, S; Mayer, G; Müller, J; Oldenburg, J; Pötzsch, B; Rohrbach, F | 1 |
| Aguilera, JA; Konigsfeld, KM; Milligan, JR; Perry, CC; Tang, VJ | 1 |
| Young, G | 2 |
| Joshi, R; Kumar, A; Manral, S; Parmar, VS; Prasad, AK; Raj, HG; Rohil, V; Singh, U; Sinha, R; Sushama, A | 1 |
| Kamijo, S; Kawasaki, T | 1 |
| Austin, JH; Paciullo, CA; Stearns, CR; Winkler, AM | 1 |
| Knovich, MA; Lesser, GJ; Strowd, RE | 1 |
| Azuma, S; Lum, CJ | 1 |
| Burger, CF; Schlesinger, JJ | 1 |
| Fabris, F; Furian, L; Nordio, M; Treleani, M; Vianello, F | 1 |
| Kadauke, S; Khor, B; Van Cott, EM | 1 |
| Baneham, S; Cox, D; Kirby, BP; Moollan, A; O'Donnell, A; Ozgul, M; Pabari, RM; Ramtoola, Z | 1 |
| Pires, MM; Sabulski, MJ; Wang, Y | 1 |
| Bojic, D; Drmic, D; Hrelec Patrlj, M; Kokot, A; Kolenc, D; Radic, B; Seiwerth, S; Sikiric, P; Stupnisek, M; Suran, J; Vcev, A; Zenko Sever, A | 1 |
| Ito, S; McAlister, RK | 1 |
| Abel, S; Böttcher, C; Chutia, R; Müller, J; Scheel, D; Schmidt, S; Strehmel, N; Ziegler, J | 1 |
| Gates, C; Neave, L; Scully, M | 1 |
| Male, C; van Ommen, CH; Young, G | 1 |
| Abramov, D; Birks, E; Bitar, A; Lenneman, A; Massey, T; Slaughter, M; Vijayakrishnan, R | 1 |
| Boivin, G; Checkmahomed, L; Couture, C; Hamelin, MÈ; Jandrot-Perrus, M; Lê, BV; Venable, MC | 1 |
| Gupta, S; Monpara, J; Vavia, P; Velga, D; Verma, T | 1 |
| Blotnick, S; Caraco, Y; Deutsch, L; Rosenberg, G; Shaul, C | 1 |
| Ageno, W; Agnelli, G; Chan, NC; De Caterina, R; Diener, HC; Hylek, E; Lip, GYH; Raskob, GE; Siegal, DM; Verheugt, FWA; Weitz, JI | 1 |
| Ieda, N; Kawaguchi, M; Nakagawa, H; Ohta, Y; Osada, S; Wakita, H | 1 |
| Curtis, BR; Erdil, RM; Gilyard, SN; Knelson, EH; Leaf, RK; Malhotra, R; Puram, RV; Ranganathan, R; Van Beuningen, AM; Wallwork, R; Weber, BN | 1 |
| Bai, Y; Chen, G; Hou, Z; Li, J; Li, M; Li, Z; Luo, L; Luo, X; Qu, D; Su, S; Wang, Y; Xue, X; Ye, Z; Zhang, X | 1 |
| Chapman, K; Makhija, K; Prasad, R | 1 |
| Amini-Khoei, H; Bijad, E; Lorigooini, Z; Maghsoudi, F; Moradi, M; Nasiri Boroujeni, S; Rahimi-Madiseh, M | 1 |
| Baloch, Z; Coffman, FD; Cohen, S | 1 |
| Gottesfeld, JM | 1 |
| Naumann, U; Weit, S; Weller, M; Wischhusen, J | 1 |
| Guo, D; Hou, L; Mao, P; Mo, L; Xiao, X; Yang, X | 1 |
24 review(s) available for arginine and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Molecular approaches to antithrombotic therapy.
Topics: Amino Acid Chloromethyl Ketones; Antithrombins; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Protease Inhibitors; Sulfonamides; Thrombin; Warfarin | 1992 |
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 1999 |
Anticoagulant therapy in unstable angina.
Topics: Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Warfarin | 1999 |
Anticoagulation: the present and future.
Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzylamines; Binding Sites; Biological Availability; Blood Coagulation; Comorbidity; Coumarins; Drug Design; Embolism; Female; Forecasting; Glycine; Guanidines; Heart Diseases; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Neoplasms; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Safety; Serine; Stroke; Sulfonamides; Thrombin; Thrombophilia; Thrombosis | 2001 |
Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin | 2002 |
Direct thrombin inhibitors.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombosis; Warfarin | 2004 |
Heparin-induced thrombocytopenia: diagnosis and management.
Topics: Anticoagulants; Aortic Valve Insufficiency; Arginine; Autoantibodies; Autoimmune Diseases; Female; Fingers; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Ischemia; Middle Aged; Necrosis; Pipecolic Acids; Platelet Activation; Platelet Factor 4; Postoperative Complications; Raynaud Disease; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Toes; Warfarin | 2004 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin | 2004 |
Thrombin-directed inhibitors: pharmacology and clinical use.
Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Warfarin | 2005 |
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2005 |
Evolving management strategies for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin | 2005 |
Anticoagulant use in patients with chronic renal impairment.
Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Heparin; Hirudins; Humans; Kidney Failure, Chronic; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Warfarin | 2005 |
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin | 2006 |
Argatroban for anticoagulation during cardiac surgery.
Topics: Adult; Aged; Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Drug Monitoring; Endocarditis, Bacterial; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Middle Aged; Mitral Valve; Pipecolic Acids; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Subclavian Vein; Sulfonamides; Thrombosis; Venous Thrombosis; Warfarin; Whole Blood Coagulation Time | 2007 |
Heparin induced thrombocytopenia: diagnosis and management update.
Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2007 |
Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 2010 |
Heparin-induced thrombocytopenia: what clinicians need to know.
Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin | 2009 |
Laboratory monitoring of new anticoagulants.
Topics: Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Chromogenic Compounds; Drug Monitoring; Factor Xa Inhibitors; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Warfarin | 2010 |
Old and new antithrombotic drugs in neonates and infants.
Topics: Anticoagulants; Arginine; Fondaparinux; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infant; Infant, Newborn; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Venous Thromboembolism; Warfarin | 2011 |
Anticoagulants in children and adolescents.
Topics: Adolescent; Anticoagulants; Arginine; Child; Clinical Trials as Topic; Fondaparinux; Hematology; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Treatment Outcome; Warfarin | 2015 |
How we manage patients with heparin induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Disease Management; Fondaparinux; Heparin; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia; Warfarin | 2016 |
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Atrial Fibrillation; Benzamides; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Dabigatran; Drug Administration Schedule; Factor Xa; Heart Diseases; Humans; Piperazines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Risk; Rivaroxaban; Stroke; Thiazoles; Thrombin; Venous Thromboembolism; Vitamin K; Warfarin | 2019 |
5 trial(s) available for arginine and warfarin
| Article | Year |
|---|---|
Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.
Topics: Adult; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor X; Hemostatics; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thromboplastin; Warfarin | 2001 |
Lack of pharmacokinetic interactions between argatroban and warfarin.
Topics: Adult; Analysis of Variance; Anticoagulants; Area Under Curve; Arginine; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pipecolic Acids; Sulfonamides; Warfarin | 2002 |
Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Chromogenic Compounds; Factor X; Female; Hospitals, University; Humans; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Predictive Value of Tests; Prospective Studies; ROC Curve; Sulfonamides; Warfarin | 2005 |
Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Infusions, Intravenous; International Normalized Ratio; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2005 |
Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Topics: Adult; Aged; Amputation, Surgical; Arginine; Cause of Death; Female; Hemorrhage; Heparin; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Assessment; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin | 2005 |
85 other study(ies) available for arginine and warfarin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Arginine esterase in amniotic fluid: possible marker for cystic fibrosis.
Topics: Amniotic Fluid; Arginine; Benzoates; Carboxylic Ester Hydrolases; Coumarins; Cystic Fibrosis; Esterases; Female; Genetic Markers; Humans; Methods; Pregnancy | 1979 |
[Investigations on the mutagenic activity of coumarin derivatives in chlamydomonas. I. The influence of irradiation with different light qualities on the frequency of reversion of an arginine-requiring mutant (author's transl)].
Topics: Arginine; Chlamydomonas; Coumarins; Dose-Response Relationship, Radiation; Light; Mutagens; Mutation; Ultraviolet Rays | 1977 |
Specificity and mode of action of the muscle-type protein-arginine deiminase.
Topics: Amino Acid Sequence; Animals; Arginine; Bradykinin; Coumarins; Dynorphins; Hydrolases; Hydrolysis; Molecular Sequence Data; Muscles; Neurotensin; Oligopeptides; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Rabbits; Structure-Activity Relationship; Substrate Specificity; Trypsin Inhibitor, Bowman-Birk Soybean | 1992 |
An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma.
Topics: Adolescent; Adult; Antithrombins; Arginine; Benzamidines; Blood Coagulation Tests; Dipeptides; Guanidines; Humans; Pipecolic Acids; Prothrombin; Sulfonamides; Warfarin | 1991 |
Purification and characterization of two soluble Cl(-)-activated arginyl aminopeptidases from human brain and their endopeptidase action on neuropeptides.
Topics: Aged; Aminopeptidases; Anions; Arginine; Cations; Cerebral Cortex; Chlorides; Chromatography, Ion Exchange; Coumarins; Drug Stability; Endopeptidases; Female; Humans; Hydrogen-Ion Concentration; Hydrolysis; Neuropeptides; Substrate Specificity | 1988 |
An evaluation of the utility of benzoyl-DL-arginine-beta-naphthyl-amide for the assay of thrombin activity in blood.
Topics: Animals; Arginine; Benzamides; Cattle; Coronary Disease; Coumarins; Factor VIII; Fibrinogen; Hirudins; Humans; Hydrolysis; Naphthalenes; Protein Binding; Prothrombin; Serum Albumin; Thrombin; Thromboplastin | 1974 |
Sodium dodecyl sulfate and hydrophobic regions in bovine serum albumin.
Topics: Animals; Arginine; Binding Sites; Cattle; Chemical Phenomena; Chemistry; Coumarins; Dioxins; Ethylamines; Fatty Alcohols; Fluorescent Dyes; Hydrogen Peroxide; Hydrogen-Ion Concentration; Naphthoquinones; Protein Binding; Protein Conformation; Protein Denaturation; Serum Albumin, Bovine; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence; Sulfonic Acids; Surface-Active Agents; Tryptophan | 1972 |
A TAMe micromethod for the measurement of "esterase prothrombin".
Topics: Aminocaproates; Arginine; Esterases; Esters; Factor V; Factor VII; Factor X; Humans; Hydrogen-Ion Concentration; Liver; Methods; Microchemistry; Oxalates; Prothrombin; Prothrombin Time; Streptokinase; Thrombin; Thromboplastin; Toluene; Venoms; Warfarin | 1970 |
Measurement of trypsin-like activity of saliva, serum and meconium by a synthetic substrate carbobenzoxy-L-arginine-7-amino-4-methylcoumarin amide (CAMCA).
Topics: Adult; Arginine; Child; Coumarins; Cystic Fibrosis; Humans; Infant, Newborn; Meconium; Saliva; Trypsin | 1984 |
Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates.
Topics: Animals; Arginine; Cathepsin B; Cathepsin H; Cathepsins; Coumarins; Cysteine Endopeptidases; Dipeptides; Humans; Lysosomes; Rats; Spectrometry, Fluorescence; Substrate Specificity | 1980 |
Proteinases are involved in both DNA fragmentation and membrane damage during CTL-mediated target cell killing.
Topics: Animals; Arginine; Aurintricarboxylic Acid; Cells, Cultured; Coumarins; Cytotoxicity, Immunologic; DNA; Endopeptidases; Isocoumarins; Kinetics; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Protease Inhibitors; Substrate Specificity; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Tyrosine | 1995 |
Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
Topics: Amino Acid Sequence; Animals; Arginine; Benzamidines; Binding Sites; Cattle; Chymases; Coumarins; Esters; Humans; Molecular Sequence Data; Organophosphorus Compounds; Rats; Serine Endopeptidases; Skin; Substrate Specificity; Trypsin; Trypsin Inhibitors; Tryptases | 1995 |
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men.
Topics: Adult; Arginine; Caffeine; Coumarins; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Heme; Humans; Isoenzymes; Lidocaine; Male; Middle Aged; Porphyrias, Hepatic; Reference Values | 1994 |
HOCGO and DMACGO. Two coumarin derived alpha-dicarbonyls suitable as pH and polarity sensitive fluorescent reporters for proteins that can be targeted at reactive arginines.
Topics: Animals; Arginine; Binding Sites; Cattle; Coumarins; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Phenylglyoxal; Proteins; Rabbits; Solvents; Spectrophotometry | 1994 |
Purification and characterization of two isoforms of serine proteinase from the microsomal membranes of rat liver.
Topics: Amino Acid Sequence; Animals; Arginine; Chromatography, Gel; Chromatography, Ion Exchange; Coumarins; Electrophoresis, Polyacrylamide Gel; Hydrolysis; Kinetics; Male; Metals; Microsomes, Liver; Molecular Sequence Data; Molecular Weight; Peptides; Rats; Rats, Wistar; Serine Endopeptidases; Serine Proteinase Inhibitors; Substrate Specificity | 1993 |
Substrate specificity of a novel serine protease from soybean [Glycine max (L.) Merrill].
Topics: Amino Acid Sequence; Antigens, Plant; Arginine; Binding Sites; Coumarins; Dynorphins; Enkephalin, Methionine; Globulins; Glycine max; Molecular Sequence Data; Oligopeptides; Protein Precursors; Seed Storage Proteins; Serine Endopeptidases; Soybean Proteins; Substrate Specificity | 1996 |
Internally consistent libraries of fluorogenic substrates demonstrate that Kex2 protease specificity is generated by multiple mechanisms.
Topics: Arginine; Binding, Competitive; Coumarins; Fluorescent Dyes; Kinetics; Oligopeptides; Proprotein Convertases; Saccharomyces cerevisiae Proteins; Substrate Specificity; Subtilisins | 1997 |
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Blood Coagulation Factors; Blood Coagulation Tests; Drug Monitoring; Drug Therapy, Combination; Factor X; False Positive Reactions; Female; Heparin; Humans; Indicators and Reagents; Male; Pipecolic Acids; Prothrombin Time; Reference Values; Reproducibility of Results; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 1997 |
Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation.
Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Case-Control Studies; Factor V; Female; Glycine; Humans; Immunoenzyme Techniques; Linear Models; Male; Middle Aged; Phenprocoumon; Point Mutation; Polymerase Chain Reaction; Statistics, Nonparametric; Warfarin | 1998 |
Probing the binding of coumarins and cyclothialidines to DNA gyrase.
Topics: Adenosine Triphosphate; Arginine; Asparagine; Aspartic Acid; Binding Sites; Coumarins; DNA Topoisomerases, Type II; Enzyme Inhibitors; Hydrolysis; Kinetics; Mutagenesis, Site-Directed; Peptides, Cyclic; Surface Plasmon Resonance; Topoisomerase II Inhibitors; Trypsin | 1999 |
The International Normalized Ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used.
Topics: Anticoagulants; Arginine; Humans; International Normalized Ratio; Pipecolic Acids; Prothrombin Time; Sulfonamides; Thromboplastin; Warfarin | 1999 |
Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics.
Topics: Amino Acid Substitution; Arginine; Dialysis; Histidine; Humans; Hyperthyroxinemia; Kinetics; Mutagenesis, Insertional; Mutation; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Warfarin | 2000 |
Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion.
Topics: alpha-Macroglobulins; Antithrombins; Arginine; Blood Coagulation; Calcium; Coumarins; Diffusion; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Kinetics; Models, Theoretical; Pipecolic Acids; Plasma; Solutions; Sulfonamides; Thrombin | 2000 |
Synthesis and enzymatic evaluation of a P1 arginine aminocoumarin substrate library for trypsin-like serine proteases.
Topics: Arginine; Coumarins; Humans; Oligopeptides; Peptide Library; Protein Conformation; Serine Endopeptidases; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Structure-Activity Relationship; Substrate Specificity; Thrombin; Trypsin | 2000 |
The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
Topics: Administration, Oral; Amidines; Animals; Arginine; Azepines; Bleeding Time; Carotid Artery Thrombosis; Dalteparin; Drug Evaluation, Preclinical; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Molecular Structure; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin; Vena Cava, Inferior; Venous Thrombosis; Warfarin | 2001 |
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin | 2001 |
Comment: treatment of heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin | 2002 |
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Arginine; Autoimmune Diseases; Catheterization, Central Venous; Contraindications; Drug Administration Schedule; Drug Therapy, Combination; Female; Gangrene; Heparin; Hirudin Therapy; Hirudins; Humans; International Normalized Ratio; Leg; Male; Middle Aged; Necrosis; Pipecolic Acids; Protein C Deficiency; Recombinant Proteins; Sulfonamides; Surgical Wound Infection; Thrombin; Thrombocytopenia; Thrombophlebitis; Warfarin | 2002 |
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin | 2002 |
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9.
Topics: Amino Acid Substitution; Arginine; Aryl Hydrocarbon Hydroxylases; Aspartic Acid; Binding Sites; Cytochrome P-450 CYP2C9; Diclofenac; Enzyme Stability; Gene Expression; Histidine; Humans; Kinetics; Models, Molecular; Mutagenesis; Pyrenes; Substrate Specificity; Warfarin | 2004 |
Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
Topics: Amino Acid Sequence; Amino Acid Substitution; Arginine; Aryl Hydrocarbon Hydroxylases; Binding Sites; Computer Simulation; Coumarins; Cytochrome P-450 CYP2A6; Enzyme Activation; Hydroxylation; Mixed Function Oxygenases; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Protein Conformation; Sequence Homology, Amino Acid; Structure-Activity Relationship; Umbelliferones; Valine | 2004 |
Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Arginine; Binding Sites; Binding, Competitive; Chromatography, Affinity; Coumarins; DNA Gyrase; Drug Design; Escherichia coli Proteins; Magnesium; Molecular Sequence Data; Novobiocin; Peptide Fragments | 2005 |
Comment: extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.
Topics: Aged; Anticoagulants; Arginine; Humans; International Normalized Ratio; Kidney; Kidney Function Tests; Liver; Lung Neoplasms; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Venous Thrombosis; Warfarin | 2005 |
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin | 2005 |
Oxidation of Arg-410 promotes the elimination of human serum albumin.
Topics: Amino Acid Sequence; Animals; Arginine; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Ketoprofen; Liver; Male; Mice; Oxidation-Reduction; Point Mutation; Protein Conformation; Serum Albumin; Warfarin | 2006 |
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
Topics: Adolescent; Adult; Aged; Antibodies, Catalytic; Arginine; Binding Sites, Antibody; Blood Coagulation; Child; Coumarins; Factor VIII; Hemophilia A; Humans; Hydrolysis; Immunoglobulin G; Middle Aged; Oligopeptides; Phenylalanine; Proline | 2006 |
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
[Bilateral cerebellar infarction caused by intracranial dissection of the vertebral artery after long periods of "Shiatsu"].
Topics: Acupressure; Acute Disease; Angiography; Anticoagulants; Arginine; Cerebellum; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Female; Humans; Infusions, Intravenous; Middle Aged; Pipecolic Acids; Sulfonamides; Tomography, X-Ray Computed; Vertebral Artery Dissection; Warfarin | 2007 |
Partial reversal of hemolysis-associated pulmonary arterial hypertension in response to oral administration of L-arginine in a patient with hereditary spherocytosis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arginine; Aspirin; Hemolysis; Humans; Hypertension, Pulmonary; Male; Middle Aged; Spherocytosis, Hereditary; Vasodilator Agents; Warfarin | 2007 |
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2008 |
Heparin-induced thrombocytopenia complicating hemodialysis.
Topics: Adult; Anticoagulants; Arginine; Calciphylaxis; Drug Contamination; Female; Heparin; Humans; Necrosis; Pipecolic Acids; Renal Dialysis; Renal Insufficiency; Skin Diseases; Sulfonamides; Thrombocytopenia; Warfarin | 2008 |
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
Topics: Acute Disease; Anticoagulants; Arginine; Blood Coagulation; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Platelet Count; Polysaccharides; Recombinant Proteins; Research Design; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome; Venous Thrombosis; Warfarin | 2008 |
Solubility enhancement of gluten and organic compounds by arginine.
Topics: Arginine; Coumarins; Gallic Acid; Glutens; Nephelometry and Turbidimetry; Organic Chemicals; Sodium Chloride; Solubility | 2008 |
[Are new anticoagulants better?].
Topics: Anticoagulants; Arginine; Drugs, Investigational; Factor Xa Inhibitors; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombosis; Warfarin | 2007 |
Arginine increases the solubility of coumarin: comparison with salting-in and salting-out additives.
Topics: Arginine; Benzyl Alcohols; Biochemistry; Caffeine; Coumarins; Dose-Response Relationship, Drug; Guanidine; Hydrogen-Ion Concentration; Models, Biological; Salts; Solubility; Surface Properties; Urea; Water | 2008 |
Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT.
Topics: Aged; Antibodies, Anticardiolipin; Anticoagulants; Arginine; Catheterization; Contraindications; Drug Therapy, Combination; Femoral Vein; Heparin; Humans; Iliac Vein; Infusions, Intravenous; Ischemia; Kidney; Kidney Transplantation; Male; Pipecolic Acids; Popliteal Vein; Postoperative Complications; Protein S Deficiency; Purpura, Thrombocytopenic, Idiopathic; Renal Veins; Sulfonamides; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator; Vena Cava Filters; Venous Thrombosis; Warfarin | 2009 |
HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Iloprost; Length of Stay; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Warfarin | 2009 |
Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin.
Topics: Aldehydes; Arginine; Chemical Phenomena; Glycation End Products, Advanced; Humans; Ketoprofen; Protein Binding; Serum Albumin; Warfarin | 2010 |
Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up.
Topics: Aged; Anticoagulants; Arginine; Embolism, Cholesterol; Fatal Outcome; Heparin; Humans; Male; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2009 |
A quantitative technique for determining proteases and their substrate specificities and pH optima in crude enzyme extracts.
Topics: Aminopeptidases; Arginine; Coumarins; Electrophoresis, Polyacrylamide Gel; Enzyme Assays; Fluorescent Dyes; Hydrogen-Ion Concentration; Peptide Hydrolases; Phaseolus; Plant Extracts; Plant Leaves; Plant Proteins; Substrate Specificity | 2009 |
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin | 2011 |
Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Topics: Aged; Anticoagulants; Arginine; Atrial Fibrillation; Blood Coagulation Tests; Carotid Stenosis; Endarterectomy, Carotid; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Warfarin | 2011 |
Profiling of active thrombin in human blood by supramolecular complexes.
Topics: Aptamers, Nucleotide; Arginine; Binding Sites; Blood Coagulation; Coumarins; Enzyme Assays; Humans; Limit of Detection; Peptides; Pipecolic Acids; Sensitivity and Specificity; Sulfonamides; Thrombin | 2011 |
Use of a coumarin-labeled hexa-arginine peptide as a fluorescent hydroxyl radical probe in a nanoparticulate plasmid DNA condensate.
Topics: Arginine; Coumarins; DNA; Fluorescent Dyes; Hydroxyl Radical; Ligands; Molecular Structure; Nanoparticles; Particle Size; Peptides; Plasmids; Staining and Labeling; Stereoisomerism; Surface Properties | 2011 |
Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
Topics: Acetates; Acetylation; Acetyltransferases; Adenosine Diphosphate; Arginine; Blood Platelets; Cells, Cultured; Coumarins; Cyclic GMP; Cytochrome Reductases; Enzyme Inhibitors; Fluoresceins; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Platelet Aggregation; Polyphenols; Structure-Activity Relationship | 2012 |
Inhibition of aggregation of amyloid β42 by arginine-containing small compounds.
Topics: Amyloid; Amyloid beta-Peptides; Arginine; Benzothiazoles; Coumarins; Dipeptides; Electrophoresis, Polyacrylamide Gel; Humans; Peptide Fragments; Polymerization; Protein Binding; Small Molecule Libraries; Solubility; Solutions; Thiazoles | 2012 |
Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
Topics: Academic Medical Centers; Anticoagulants; Arginine; Blood Coagulation; Chromogenic Compounds; Databases, Factual; Drug Administration Schedule; Electronic Health Records; Factor X; Hospitals, Teaching; Humans; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sulfonamides; Warfarin | 2012 |
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
A comparison of methods for estimating glomerular filtration rate for a population in Hawai'i with non-valvular atrial fibrillation.
Topics: Aged, 80 and over; Anticoagulants; Arginine; Asian People; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Glomerular Filtration Rate; Hawaii; Humans; Male; Morpholines; Pipecolic Acids; Retrospective Studies; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2013 |
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2014 |
Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Polycystic Kidney Diseases; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin | 2015 |
Activated protein C resistance testing for factor V Leiden.
Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2014 |
Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
Topics: Administration, Intranasal; Administration, Intravenous; Analgesics; Animals; Arginine; Cell Line; Central Nervous System; Coumarins; Dogs; Drug Delivery Systems; Female; Lactic Acid; Loperamide; Male; Mice, Inbred C57BL; Nanoconjugates; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Thiazoles | 2015 |
PAD2 Activity Monitored via a Fluorescent Substrate Analog.
Topics: Arginine; Benzamides; Calcium; Citrulline; Coumarins; Enzyme Assays; Enzyme Inhibitors; Fluorescent Dyes; Hydrogen-Ion Concentration; Hydrolases; Kinetics; Protein Processing, Post-Translational; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Spectrometry, Fluorescence; Trypsin | 2015 |
Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.
Topics: Amputation, Surgical; Animals; Anticoagulants; Arginine; Drug Evaluation, Preclinical; Hemorrhage; Hemostasis; Heparin; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteins; Rats, Wistar; Thrombocytopenia; Warfarin | 2015 |
Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin | 2015 |
Non-targeted profiling of semi-polar metabolites in Arabidopsis root exudates uncovers a role for coumarin secretion and lignification during the local response to phosphate limitation.
Topics: Arabidopsis; Arginine; Citric Acid; Cluster Analysis; Coumarins; Hydroponics; Lignin; Malates; Meristem; Metabolome; Metabolomics; Phloroglucinol; Phosphates; Plant Exudates; Plant Roots | 2016 |
Anticoagulation in children: Making the most of little patients and little evidence.
Topics: Anticoagulants; Arginine; Blood Coagulation; Child; Drug Monitoring; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombosis; Venous Thromboembolism; Warfarin | 2017 |
The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
Topics: Adult; Aged; Anticoagulants; Arginine; Eptifibatide; Female; Heart Failure; Heart-Assist Devices; Hemolysis; Heparin; Humans; Male; Middle Aged; Peptides; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombosis; Warfarin; Young Adult | 2017 |
Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.
Topics: Animals; Anticoagulants; Arginine; Disease Models, Animal; Heparin; Metapneumovirus; Mice; Paramyxoviridae Infections; Pipecolic Acids; Sulfonamides; Survival Analysis; Treatment Outcome; Viral Load; Virus Replication; Warfarin | 2018 |
Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies.
Topics: Arginine; Cations; Cholesterol; Circular Dichroism; Computer Simulation; Coumarins; DNA; Gene Transfer Techniques; Genetic Therapy; HEK293 Cells; Humans; Liposomes; Molecular Dynamics Simulation; Particle Size; Phosphatidylcholines | 2019 |
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin.
Topics: Adult; Anticoagulants; Arginine; Blood Coagulation; Cytochrome P-450 CYP2C9; Drug Monitoring; Factor VII; Genotype; Glutamine; Humans; International Normalized Ratio; Linear Models; Male; Multivariate Analysis; Polymorphism, Single Nucleotide; Vitamin K Epoxide Reductases; Warfarin; Young Adult | 2019 |
Ratiometric assay of CARM1 activity using a FRET-based fluorescent probe.
Topics: Arginine; Coumarins; Fluorescein; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Molecular Structure; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases | 2019 |
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Eptifibatide; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Stents; Sulfonamides; Thrombectomy; Thrombolytic Therapy; Thrombosis; Ticagrelor; Warfarin | 2020 |
A new coumarin compound DCH combats methicillin-resistant
Topics: Anti-Bacterial Agents; Arginine; Biofilms; Coumarins; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation | 2020 |
A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
Topics: Aged; Anticoagulants; Arginine; Heparin; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Warfarin | 2021 |
Possible involvement of L-arginine-nitric oxide pathway in the antidepressant activity of Auraptene in mice.
Topics: Animals; Antidepressive Agents; Arginine; Behavior, Animal; Coumarins; Depression; Male; Mice; Nitric Oxide; Swimming | 2022 |
Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
Topics: Aminocoumarins; Camptothecin; Cell Line; Cell Survival; Coumarins; Drug Synergism; In Vitro Techniques; L Cells; Novobiocin; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Necrosis Factor-alpha | 1990 |
Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II.
Topics: Aminocoumarins; Camptothecin; Coumarins; DNA-Directed RNA Polymerases; HeLa Cells; Novobiocin; RNA Polymerase III; RNA, Ribosomal; RNA, Transfer; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic | 1986 |
Diva/Boo is a negative regulator of cell death in human glioma cells.
Topics: Apoptotic Protease-Activating Factor 1; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Death; Central Nervous System Neoplasms; Coumarins; Culture Media, Serum-Free; Cytochrome c Group; Enzyme Inhibitors; Fas Ligand Protein; Genes, myc; Glioma; Humans; Membrane Glycoproteins; Nitrosourea Compounds; Oligopeptides; Proteins; Proto-Oncogene Proteins c-bcl-2; Teniposide; Transfection; Tumor Cells, Cultured | 2001 |
Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Topics: Acetone; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Endocytosis; Fluorescent Dyes; Glioblastoma; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Teniposide; Thiazoles | 2012 |